AstraZeneca share price: Company may have to deal with Pfizer once again

By: Anton Aleksandrov
Anton Aleksandrov
Anton is a freshly graduated economist from the States with passion for the world of finance. He is one… read more.
on May 23, 2014

The board of AstraZeneca may have to deal with US pharmaceutical giant Pfizer once again. One of the AstraZeneca’s biggest shareholder, Blackrock, says although it supported the decision to reject Pfizer’s bid, it wants the two pharmaceutical companies to continue talks at a later date. However no deal can be discussed for three months because of the UK takeover rules.

Invest in crypto, stocks, ETFs & more in minutes with our preferred broker, eToro
67% of retail CFD accounts lose money